Reference health
Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells
46/46 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 46 checked references that resolve
resolves10.1099/00221287-147-8-2029
A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59
b
bThe GenBank accession numbers for the sequences determined in this work are AF337642, L22866, AF337643, AF337644 and AF337645.
resolves10.1080/13693780701386015
Acute respiratory distress syndrome due to<i>Cryptococcus albidus</i>pneumonia: Case report and review of the literature
resolves10.1097/01.ico.0000157404.34774.1a
Cryptococcus albidus Keratitis After Corneal Transplantation
resolves10.1097/01.ico.0000126322.13143.7b
Scleral Ulceration Caused by Cryptococcus albidus in a Patient With Acquired Immune Deficiency Syndrome
resolves10.1111/j.1439-0507.1998.tb00338.x
Fungaemia due to <i>Cryptococcus laurentii</i> and a review of non‐<i>neoformans</i> cryptococcaemia
resolves10.1128/IAI.63.7.2632-2644.1995
Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion
resolves10.1128/IAI.18.3.701-707.1977
Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness
resolves10.1128/IAI.5.6.896-901.1972
Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique
resolves10.1016/S0966-842X(01)02134-5
Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens
resolves10.1128/IAI.63.8.2919-2923.1995
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes
resolves10.1016/S0065-2164(09)01204-0
Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans
resolves10.1016/0008-6215(95)00397-5
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy
resolves10.1128/IAI.62.5.1507-1512.1994
Polysaccharide antigens of the capsule of Cryptococcus neoformans
resolves10.1128/CDLI.5.2.146-159.1998
<i>Cryptococcus neoformans</i>Chemotyping by Quantitative Analysis of<sup>1</sup>H Nuclear Magnetic Resonance Spectra of Glucuronoxylomannans with a Computer-Simulated Artificial Neural Network
resolves10.1128/EC.00162-07
Capsule Structural Heterogeneity and Antigenic Variation in
<i>Cryptococcus neoformans</i>
resolves10.1111/j.1365-2958.2010.07511.x
Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity
resolves10.1128/IAI.00111-10
Immunomodulatory Effects of Serotype B Glucuronoxylomannan from
<i>Cryptococcus gattii</i>
Correlate with Polysaccharide Diameter
resolves10.1128/EC.00378-07
<i>Cryptococcus neoformans</i>
Capsular Polysaccharide and Exopolysaccharide Fractions Manifest Physical, Chemical, and Antigenic Differences
resolves10.1073/pnas.0808995106
Capsule of
<i>Cryptococcus neoformans</i>
grows by enlargement of polysaccharide molecules
resolves10.1128/IAI.54.3.742-750.1986
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants
resolves10.1128/JCM.34.9.2290-2291.1996
Modified India ink preparation for Cryptococcus neoformans in cerebrospinal fluid specimens
resolves10.1128/EC.00122-07
Self-Aggregation of
<i>Cryptococcus neoformans</i>
Capsular Glucuronoxylomannan Is Dependent on Divalent Cations
resolves10.1128/EC.00142-09
Role for Chitin and Chitooligomers in the Capsular Architecture of
<i>Cryptococcus neoformans</i>
resolves10.1128/EC.00307-07
Binding of the Wheat Germ Lectin to
<i>Cryptococcus neoformans</i>
Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan
resolves10.1016/j.fgb.2009.03.003
Structural and functional properties of the Trichosporon asahii glucuronoxylomannan
resolves10.1128/JCM.29.1.192-196.1991
Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis
resolves10.1016/0022-1759(92)90209-C
Monoclonal antibody based ELISAs for cryptococcal polysaccharide
resolves10.1128/IAI.69.5.3398-3409.2001
Molecular Basis for Immunoglobulin M Specificity to Epitopes in<i>Cryptococcus neoformans</i>Polysaccharide That Elicit Protective and Nonprotective Antibodies
resolves10.1080/02681218980000291
Phagocytosis of<i>Cryptococcus neoformans</i>by rat alveolar macrophages
resolves10.1128/IAI.71.9.4862-4872.2003
<i>Cryptococcus neoformans</i>Virulence Is Enhanced after Growth in the Genetically Malleable Host<i>Dictyostelium discoideum</i>
resolves10.1073/pnas.261418798
<i>Cryptococcus neoformans</i>
interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages
resolves10.1128/IAI.00094-07
The Relative Susceptibility of Mouse Strains to Pulmonary<i>Cryptococcus neoformans</i>Infection Is Associated with Pleiotropic Differences in the Immune Response
resolves10.1111/j.1462-5822.2008.01186.x
Capsule enlargement in<i>Cryptococcus neoformans</i>confers resistance to oxidative stress suggesting a mechanism for intracellular survival
resolves10.1371/journal.ppat.0030101
Exploiting Amoeboid and Non-Vertebrate Animal Model Systems to Study the Virulence of Human Pathogenic Fungi
resolves10.1590/S0074-02762001000300019
Anesthesia of Biomphalaria spp. (Mollusca, Gastropoda): sodium pentobarbital is the drug of choice
resolves10.1128/JCM.31.2.463-464.1993
Fast DNA isolation from Histoplasma capsulatum: methodology for arbitrary primer polymerase chain reaction-based epidemiological and clinical studies
resolves10.1128/EC.4.2.465-475.2005
Radiological Studies Reveal Radial Differences in the Architecture of the Polysaccharide Capsule of<i>Cryptococcus neoformans</i>
resolves10.1046/j.1365-2958.2003.03780.x
Cell wall α‐1,3‐glucan is required to anchor the
<i>Cryptococcus neoformans</i>
capsule
resolves10.1074/jbc.M509465200
The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction
The 5 references without a DOI — listed, not checked
no DOI — not checked<italic>Cryptococcus neoformans</italic>, vol.
no DOI — not checkedGlobal warming will bring new fungal diseases for mammals.
no DOI — not checkedMammalian endothermy optimally restricts fungi and metabolic costs.
no DOI — not checkedPhagocytosis and Non-Lytic Exocytosis of <italic>Cryptococcus neoformans</italic> by and from <italic>Acanthamoeba Castellanii</italic>.
no DOI — not checkedMacrophage-Cryptococcus interactions.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1371/journal.pone.0029561"><img src="https://citestamp.com/citestamped/10.1371/journal.pone.0029561/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1371/journal.pone.0029561)